Atlas Trials

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

Clinical trial NCT06795503 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06795503
Sponsor
Fudan University
Status
NOT_YET_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Triple-negative Breast Cancer
Start date
2025-02-01
Primary completion
2028-08-01
Enrollment
1462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.